Explore more topics
SEC reporting owner

Lathi Vijay K SEC insider disclosures

Explore Lathi Vijay K's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001340806
Issuers
14
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

SGX PHARMACEUTICALS, INC.0001125603SGXPNoYes
WORLD HEART CORP0001024520WHRTNoNo
Transcept Pharmaceuticals Inc0001178711TSPTNoNo
ICAGEN INC0000902622ICGNNoNo
Durata Therapeutics, Inc.0001544116DRTXNoNo
MEI Pharma, Inc.0001262104MEIPNoNo
Relypsa Inc0001416792RLYPNoNo
Oxford Immunotec Global PLC0001586049OXFDNoYes
CONCERT PHARMACEUTICALS, INC.0001367920CNCENoNo
CHIMERIX INC0001117480CMRXNoNo
Versartis, Inc.0001513818VSARNoNo
iRhythm Technologies, Inc.0001388658IRTCNoYes
Iterum Therapeutics plc0001659323ITRMNoNo
Harpoon Therapeutics, Inc.0001708493HARPNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.